Ron-Bigger Shulamit
SEC CIK 2049407 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | COO | 50.0K | — | $1.39M | 2 | 2026-07-08 | 2026-07-08 |
Most active insiders at AKTS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | NODELMAN OLEG | Dir | $40.00M | — |
| 2 | MPM ONCOLOGY INNOVATIONS FUND LP | 10% | $20.03M | — |
| 3 | GADICKE ANSBERT | 10% | $20.03M | — |
| 4 | VIDA VENTURES II-A, LLC | 10% | $15.03M | — |
| 5 | Kim Helen Susan | Dir, 10% | $15.03M | — |
| 6 | Foley Todd | Dir, 10% | $4.19M | — |
| 7 | Czibere Akos | Chief Medical Off | — | $1.65M |
| 8 | Ron-Bigger Shulamit | COO | — | $1.39M |
| 9 | Herrmann Ken | Dir | — | $196.5K |
| 10 | Segal Lloyd Mitchell | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-10 06:11 | 2026-07-08 | AKTS | Aktis Oncology, Inc. | Ron-Bigger Shulamit | COO | M - OptEx | $3.66 | +50.0K | 50.0K | New | +$183.0K |
| DM | 2026-07-10 06:11 | 2026-07-08 | AKTS | Aktis Oncology, Inc. | Ron-Bigger Shulamit | COO | S - Sale+OE | $27.75 | -50.0K | 0 | -100% | -$1.39M |
Purchase Sale Sale after option exercise All abbreviations